Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportMolecular Targeting Probes-Radioactive & Nonradioactive - Automation & Technology Development

Development of automatic synthesizer and quality control methods for novel [18F] FBPA synthesis method.

Yasukazu Kanai, Toshimitsu Watanabe, Youichiro Ohta, Yoshihide Hattori, Kouki Uehara, Sadahiro Naka, Toshihiro Sakai, Naoya Kondo, Takashi Temma, Koji Ono and Mitsunori Kirihata
Journal of Nuclear Medicine June 2023, 64 (supplement 1) P274;
Yasukazu Kanai
1Kansai BNCT Medical Center, Osaka Medical and Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshimitsu Watanabe
2Sumitomo Heavy Industries, Ltd.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Youichiro Ohta
3STELLA PHARMA CORPORATION
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihide Hattori
4Osaka Metropolitan University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kouki Uehara
3STELLA PHARMA CORPORATION
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sadahiro Naka
5Osaka University Graduate School of Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshihiro Sakai
6Hanwa Intelligent Medical Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naoya Kondo
7Osaka Medical and Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takashi Temma
7Osaka Medical and Pharmaceutical University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koji Ono
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mitsunori Kirihata
4Osaka Metropolitan University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

P274

Introduction: 2-[18F]Fluoro-4-borono-phenylalanine (FBPA) is an important PET tracer for the determination of Boron Neutron Capture Therapy (BNCT) applicability. Nowadays [18F]FBPA is mostly produced from [18F]F2 gas. We previously reported a novel [18F]FBPA synthesis methods from [18F]HF which is produced by 18O(p, n)18F nuclear reaction.

While, a nuclear reactor was formerly needed for a neutron source in BNCT. A cyclotron neutron generation system was recently established. Due to this change, BNCT has possibility to expanding all over the world. As BNCT expands, we need more [18F]FBPA radioactivity in one synthesis. Since nuclear reaction yield is larger in 18O(p, n)18F nuclear reaction than 20Ne (d, α)18F. We previously reported a novel [18F]FBPA synthesis from [18F]F- which is produced by 18O(p, n)18F nuclear reaction. In this study, we tried to adopt this method for automatic synthesizer.

Methods:

We used a modified type of MPS-200 Aβ (Sumitomo Heavy Industry, Tokyo, Figure 1) as the automatic synthesizer. The synthesis scheme is shown in Scheme 1. The first step is 18F-fluorination in the first reaction vessel. In this step, 7 mg of pinacol borane precursor and 20 mg of copper reagent were used for [18F]fluorination step in first reaction vessel. The reaction condition consists of 80-degree reaction temperature and 20 min reaction time in a mixture (1/2) of n-butanol (n-BuOH) and dimethyl acetamide (DMA) mixture (1/2). After the fluorination reaction, the reaction mixture was passed through silica gel cartridge column to remove the copper reagent and transferred to second reaction vessel. In the borylation step, we used 50 mg of bis (pinacolato)diboron, 6.0 mg of bis(dibenzylidene acetone)palladium(0), 6.0 mg of tricyclohexyl phosphine and 5.0 mg of potassium acetate in dimethy formamide (DMF). The reaction temperature was 110-degree and the reaction time was 20 min. Then, the reaction mixture was passed through a tC18 cartridge and moved to third reaction vessel. Hydroiodic acid was added to reaction mixture for deprotection. The reaction condition of this step was 100 degree in reaction temparature and reaction time was 5 min. A crude mixture was purified by HPLC. Finally, [18F]FBPA fraction was collected after HPLC purification of the crude mixture. Radiochemical purity (RCP) and molar activity (MA) were determined by HPLC. The concentrations of n-BuOH, DMA and DMF were measured with gas chromatography.

Results: The radiochemical yield of [18F]FBPA from [18F]HF was more than 10% (non-decay collected). Total synthesis time from the end of bombardment was about 110 min. RCP and MA of [18F]FBPA were more than 90% and 1,000 GBq/μmol, respectively. Each concentration of n-BuOH, DMA and DMF was less than 100 ppm. About 9 GBq of [18F]FBPA was produced by our method with 60 min and 50 microA irradiation using 12 MeV cyclotron.

Conclusions: We succeeded in synthesizing [18F]FBPA from [18F]HF using an automatic synthesizer that can be used in clinical situations.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 64, Issue supplement 1
June 1, 2023
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Development of automatic synthesizer and quality control methods for novel [18F] FBPA synthesis method.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Development of automatic synthesizer and quality control methods for novel [18F] FBPA synthesis method.
Yasukazu Kanai, Toshimitsu Watanabe, Youichiro Ohta, Yoshihide Hattori, Kouki Uehara, Sadahiro Naka, Toshihiro Sakai, Naoya Kondo, Takashi Temma, Koji Ono, Mitsunori Kirihata
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P274;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Development of automatic synthesizer and quality control methods for novel [18F] FBPA synthesis method.
Yasukazu Kanai, Toshimitsu Watanabe, Youichiro Ohta, Yoshihide Hattori, Kouki Uehara, Sadahiro Naka, Toshihiro Sakai, Naoya Kondo, Takashi Temma, Koji Ono, Mitsunori Kirihata
Journal of Nuclear Medicine Jun 2023, 64 (supplement 1) P274;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Automated radiosynthesis of Tyr3-octreotate derivative [18F]SiTATE via a merging of “Silicon-Fluoride Acceptor” (SiFA) and “non-anhydrous, minimally basic” (NAMB) chemistries
  • Improved, ethanol-free [11C]butanol radiosynthesis for assessing blood-brain barrier integrity using hybrid PET/MR
  • Simple universal strategy to prepare 18F-labeled amino acid analogues
Show more Molecular Targeting Probes-Radioactive & Nonradioactive - Automation & Technology Development

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire